Biocon is the largest biotech company in India focused on delivering affordable innovation.
Biocons key innovations include an indigenous recombinant human insulin based on proprietary fermentation technology, INSUGEN, insulin analogue Glargine, BASALOG. Indias first indigenously produced monoclonal antibody BioMAb-EGFR for head & neck cancer is also developed by Biocon. INSUPen is a next generation affordable insulin delivery device introduced in India by Biocon.
Biopharmaceuticals - Small Molecules, Biosimilars, Branded Formulations are products of BIOCON.
Corporate Headquarters
Biocon
20th KM, Hosur Road,
Electronic City,
Bangalore, India - 560 100
Karnataka
Phone: +91 80 2808 2808 / 91 80 4014 4014
Fax: +91 80 2852 3423
Email: contact.us@biocon.com